Earnings Feed
Start Free
Lantern Pharma Inc.·4

Jan 13, 4:05 PM ET

KEYSER D JEFFREY 4

4 · Lantern Pharma Inc. · Filed Jan 13, 2026

Insider Transaction Report

Form 4
Period: 2026-01-09
Lantern Pharma Inc.LTRN
KEYSER D JEFFREY
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-01-09+25,000→ 25,000 total
    Exercise: $3.49Exp: 2036-01-08→ Common Stock (25,000 underlying)
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-01-09+28,844→ 28,844 total
    Exercise: $3.49Exp: 2036-01-08→ Common Stock (28,844 underlying)
Footnotes (2)
  • [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing February 9, 2026.
  • [F2]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 12-month period commencing February 9, 2026.
Signature
/s/ D. Jeffrey Keyser|2026-01-12

Documents

1 file
  • 4
    ownership.xmlPrimary

    4